EXE Financial Statements & Analysis
Complete financial statements for EXE including income statement, balance sheet, and cash flow statement. Analyze EXE's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.
Financial Health Score
Financial Health Score
Income Statement
Revenue
176.0% ↑
Net Income
354.8% ↑
Gross Margin
72.1% ↑
Operating Margin
191.9% ↑
Balance Sheet
Current Ratio
57.2% ↑
Debt to Equity
-17.9% ↑
Asset Turnover
172.1% ↑
Cash Flow
Operating Cash Flow
192.3% ↑
Net Cash Flow
139.7% ↑
Free Cash Flow
22887.5% ↑
Cash Flow to Debt
236.5% ↑
Income Statement Comparison
Revenue & Net Income
Period Comparison
| Metric | 2024 | 2025 | Change | Impact |
|---|---|---|---|---|
| Revenue | 4.22B | 11.65B | 176.0% | |
| Gross Profit | 1.14B | 5.42B | 374.8% | |
| Operating Income | -803.00M | 2.04B | 353.7% | |
| Net Income | -714.00M | 1.82B | 354.8% | |
| EPS | -4.55 | 7.67 | 268.6% | |
| EBITDA | 1.02B | 5.50B | 440.0% | |
| Gross Margin | 27.03% | 46.51% | 72.1% | |
| Operating Margin | -19.02% | 17.49% | 191.9% | |
| Net Income Margin | -16.92% | 15.62% | 192.3% | |
| R&D Expenses | 0 | 0 | 0.0% |
Income Statement Full Table
Free users can view the last 3 periods. Upgrade to see the full history.
Upgrade| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 11.65B | 4.22B | 7.78B | — | — |
| Gross Profit | 5.42B | 1.14B | 5.04B | — | — |
| Operating Income | 2.04B | -803.00M | 3.14B | — | — |
| Net Income | 1.82B | -714.00M | 2.42B | — | — |
| EPS | 7.67 | -4.55 | 18.21 | — | — |
| EBITDA | 5.50B | 1.02B | 4.76B | — | — |
| Gross Margin | 46.51% | 27.03% | 64.81% | — | — |
| Operating Margin | 17.49% | -19.02% | 40.41% | — | — |
| Net Income Margin | 15.62% | -16.92% | 31.11% | — | — |
| R&D Expenses | 0 | 0 | 0 | — | — |
Financial Metrics
Want to dive deeper into EXE's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.
View Financial Metrics